Mineralys Therapeutics names James J. Ferguson III as chief medical officer in Form 3 beneficial ownership filing
MLYS•Form 3 filing names new chief medical officer
- Mineralys Therapeutics filed a Form 3 initial beneficial ownership statement for Chief Medical Officer James J. Ferguson III dated Aug. 10, 2026.
